With offices in the UK, Europe and the U.S., Horizon offers an extensive range of catalogue products and related research services to support a greater understanding of the function of genes across all species, the genetic drivers of human disease and the development of personalized molecular, cell and gene therapies. These have been adopted by over 10,000 academic, drug discovery, drug manufacturing and clinical diagnostics customers around the globe, as well as in the Company's own R&D pipeline. Horizon's offerings are built around our proprietary translational genomics platform, a high-precision and flexible suite of gene editing tools able to alter almost any endogenous gene sequence of human or mammalian cell-lines. Based from that launch pad, Horizon now offers over 23,000 catalog products, almost all of which are based on the application of gene editing to generate cell-lines that accurately model the disease-causing mutations found in genetically based diseases.

Waste Minimization & Diversion

• • Reduction of halogenated (DCM) hazardous waste production through process changes.

  • Diverted waste to the landfill through recycling and compost programs.

Water Conservation & Quality

• • Replaced bathroom fixtures.

Corporate Social Responsibility

• • Participate in environmental clean-up projects in the community.

  • Donated goods and services to non-profits in the community.

  • Worked with students STEM event, introducing students to environmental occupations.